IncFact
Company Profiles: Revenue, Growth, Competition

RARECYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Rarecyte

Access the complete profile.

Rarecyte Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes33911
4234 Professional & Commercial Equipment & Supplies Merchant Wholesalers
5417 Scientific Research & Development Services
541714
Address2601 4th Ave Ste 500
Seattle, WA 98121

rarecyte.com
Note: Revenues for privately held companies are statistical evaluations.


Rarecyte's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.


Rarecyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Rarecyte Annual Revenue and Growth Rate

Rarecyte Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Rarecyte's revenues are gauged from an analysis of company filings.



Investor Activity

Rarecyte has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
July 25, 2023 19 37%$36 MM
Complete list of funding rounds and total amounts in the Company Report




Rarecyte's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Rarecyte Revenue (Sales) Rarecyte Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Rarecyte is developing and marketing. Rarecyte's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
A
Downloadable computer software for capturing, storing, measuring and analyzing images in the field of digital microscopy and image analysis; Downloadable computer software for image acquisition, image storage, image processing, image viewing and analysis, and image file management; Downloadable computer software for fluorescence imaging and analysis; Downloadable mobile applications for capturing, storing, measuring and analyzing images in the field of digital microscopy and image analysis
07/21/2023
LEO
Light irradiation apparatus for reducing autofluorescence in biological samples for scientific or laboratory research purposes
05/09/2022
ARTEMIS
Downloadable computer software and downloadable mobile applications for capturing, storing, measuring and analyzing images in the field of digital microscopy and image analysis; downloadable computer software for image acquisition, image storage, image processing, image viewing and analysis, and image file management; downloadable computer software for fluorescence imaging and analysis
08/09/2021

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Rarecyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Rarecyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Surgical & Medical Instrument Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Rarecyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rarecyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
EMBECTAParsippany, NJ100 
SPECIALTY SURGICAL INSTRUMENTATIONAntioch, TN24 
MIDWEST INTERVENTIONAL SYSTEMSMaple Grove, MN19 
MEDTECOrange City, IA16 
ORTHALIGNAliso Viejo, CA12 
SMART WORLDFremont, CA9 
BENTEC MEDICAL OPCOWoodland, CA9 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA9 
SONEX HEALTHEagan, MN7 




Nearby Competitors

These companies are similar in business line and location to Rarecyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
NANOSTRING TECHNOLOGIESSeattle, WA100 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA12 
RARECYTESeattle, WA11 
PROPRIOSeattle, WA7 
BODYPOINT DESIGNSSeattle, WA7 
MORAIR MEDTECHSeattle, WA6 




Future Competition: Rarecyte's Fastest Growing Competitors

These companies are in the same general field as Rarecyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Rarecyte Competitors